Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KS › Topeka › NPI 1194782409
Hospital

Stormont-Vail Healthcare INC

Stormont-Vail Healthcare INC was paid $4.59M by Medicaid between Jan 2018 and Nov 2024, across 165 billing codes. Its largest line is 99283, emergency room visit (moderate) — 27% of everything it billed.

33Billing provider infoSTORMONT-VAIL HEALTHCARE INC
TOPEKA, KS 66604
33aNPI1194782409assigned 04/28/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.59M
24GClaims279,415
24DCodes billed165
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in Kansas

Rank by total paid#7 of 48
Median peer was paid$461K
This provider vs. median10.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201862,052$1.10M
201942,543$815K
202030,753$517K
202134,186$585K
202239,575$631K
202343,827$531K
2024incomplete26,479$413K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 27% 29,731 29,181 $1.26M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 14% 14,737 14,328 $651K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 13% 16,113 15,689 $581K
80053 Comprehensive metabolic panel 7.4% 37,278 35,861 $342K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.8% 9,750 9,301 $175K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.4% 39,273 37,413 $156K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.2% 4,742 4,658 $146K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 2.7% 1,492 817 $124K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.8% 8,151 7,456 $83K
96375 Therapeutic injection; each additional sequential IV push 1.8% 2,867 2,635 $83K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.8% 2,475 2,443 $82K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 1.4% 152 149 $66K
153 more codes
81001 1.4% 17,963 $64K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.2% 825 $56K
96361 Intravenous infusion, hydration; each additional hour 1.0% 2,030 $46K
93325 <1% 753 $44K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 404 $42K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 307 $35K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 537 $30K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 1,338 $26K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 74 $26K
70450 Computed tomography, head or brain; without contrast material <1% 343 $23K
G0378 Hospital observation service, per hour <1% 720 $22K
84484 <1% 2,488 $22K
84703 <1% 2,409 $22K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 204 $20K
0240U <1% 177 $17K
83690 <1% 2,651 $17K
86140 <1% 2,864 $14K
93304 <1% 201 $14K
71046 Radiologic examination, chest; 2 views <1% 1,290 $14K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 34 $13K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 340 $12K
83735 <1% 2,209 $12K
93320 <1% 307 $12K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 158 $12K
93321 <1% 285 $12K
59025 Fetal non-stress test <1% 355 $12K
87081 <1% 1,383 $11K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 617 $11K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 70 $9K
87507 <1% 14 $9K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 61 $9K
71275 Computed tomographic angiography, chest, with contrast material <1% 67 $9K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 442 $8K
84443 Thyroid stimulating hormone (TSH) <1% 1,216 $8K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 185 $7K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 40 $6K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 118 $5K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 118 $5K
87086 Culture, bacterial; quantitative colony count, urine <1% 481 $5K
80061 Lipid panel <1% 813 $5K
72125 Computed tomography, cervical spine; without contrast material <1% 60 $5K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 13 $4K
70551 Magnetic resonance imaging, brain; without contrast material <1% 25 $4K
83605 <1% 550 $4K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 94 $4K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 71 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 445 $4K
64483 <1% 55 $4K
85610 <1% 1,431 $4K
87807 <1% 189 $3K
80164 <1% 613 $3K
85730 <1% 792 $3K
84145 <1% 162 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 323 $3K
83880 <1% 193 $2K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 29 $2K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 986 $2K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 46 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 224 $2K
80048 Basic metabolic panel (calcium, ionized) <1% 733 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 441 $2K
87040 <1% 153 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 2,012 $2K
96376 <1% 87 $2K
62369 <1% 25 $1K
87077 <1% 160 $1K
84439 <1% 127 $1K
87186 <1% 123 $1K
36415 Collection of venous blood by venipuncture <1% 37,745 $1K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,571 $1K
J7120 Ringers lactate infusion, up to 1000 cc <1% 796 $1K
87808 <1% 88 $1K
82247 <1% 145 $977.19
73502 <1% 28 $926.07
77336 <1% 20 $860.79
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 21 $857.81
82803 <1% 83 $830.75
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 12 $762.21
81025 <1% 94 $755.21
J1040 Injection, methylprednisolone acetate, 80 mg <1% 263 $748.87
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,650 $740.28
87205 <1% 141 $736.83
85379 <1% 85 $728.44
93017 <1% 42 $708.75
74018 <1% 52 $674.43
88304 <1% 58 $670.72
84702 <1% 61 $648.45
73562 <1% 46 $612.79
72100 <1% 29 $608.96
71045 Radiologic examination, chest; single view <1% 131 $606.07
64484 <1% 13 $539.02
J1815 Injection, insulin, per 5 units <1% 58 $482.42
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 903 $476.41
73630 <1% 36 $438.13
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 19 $437.34
73030 <1% 29 $430.40
73610 <1% 34 $417.00
87070 <1% 61 $409.41
86850 <1% 60 $395.15
83525 <1% 26 $379.20
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 512 $375.10
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 28 $356.57
82550 <1% 42 $322.12
86308 <1% 37 $303.15
87147 <1% 33 $293.71
86901 <1% 59 $283.41
J2270 Injection, morphine sulfate, up to 10 mg <1% 144 $279.88
81003 <1% 379 $277.25
82248 <1% 77 $276.14
73130 <1% 17 $274.78
85651 <1% 48 $265.16
86592 <1% 41 $258.24
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 129 $251.11
J0780 Injection, prochlorperazine, up to 10 mg <1% 30 $222.64
86900 <1% 59 $222.44
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 47 $216.64
85027 <1% 39 $197.09
83655 <1% 12 $188.64
J0690 Injection, cefazolin sodium, 500 mg <1% 130 $148.54
73590 <1% 14 $147.79
J2550 Injection, promethazine hcl, up to 50 mg <1% 71 $147.05
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 617 $145.45
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 677 $126.58
99152 <1% 34 $108.83
82607 <1% 14 $107.43
J2469 Injection, palonosetron hcl, 25 mcg <1% 16 $98.26
82272 <1% 31 $89.54
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 643 $76.62
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 88 $72.59
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 137 $67.46
J2704 Injection, propofol, 10 mg <1% 133 $65.35
J1170 Injection, hydromorphone, up to 4 mg <1% 28 $54.22
99153 Mod sedat endo service >5yrs <1% 13 $54.12
J2060 Injection, lorazepam, 2 mg <1% 51 $44.13
87340 <1% 18 $31.76
J1010 Injection, methylprednisolone acetate, 1 mg <1% 13 $22.84
J1644 Injection, heparin sodium, per 1000 units <1% 43 $17.73
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 15 $12.09
J1630 Injection, haloperidol, up to 5 mg <1% 65 $10.12
J3370 Injection, vancomycin hcl, 500 mg <1% 14 $9.93
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 14 $9.01
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 29 $7.82
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 25 $7.50
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 335 $6.07
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 5,893 $0.02
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 63 $0.00
C1780 Lens, intraocular (new technology) 0% 14 $0.00
36600 0% 50 $0.00
36416 0% 62 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 12 $0.00
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 0% 62 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 29 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKONGS, MICHAEL (INTERIM CFO)